MammaPrint和BluePrint在识别最有可能实现淋巴结降期和新辅助化疗后达到病理完全缓解的局部晚期乳腺癌患者中的预测作用
The Predictive Utility of MammaPrint and BluePrint in Identifying Patients with Locally Advanced Breast Cancer Who are Most Likely to Have Nodal Downstaging and a Pathologic Complete Response After Neoadjuvant Chemotherapy
DOI 原文链接
用sci-hub下载
如无法下载，请从 Sci-Hub 选择可用站点尝试。
正在获取期刊数据...
发表日期:2023 Dec
作者:
DOI:10.1245/s10434-023-14027-9
摘要
AI正在翻译并加载中文摘要...